Bobba Venkatadri
General Partner @ VenturEast
San Francisco, United States
Bobba Venkatadri is a seed investor at VenturEast in San Francisco focused on Health Care and Fitness. A General Partner with Ventureast, Bobba brings over 36 years of corporate leadership experience in the pharmaceutical and life sciences fields in the US, EU and Asia. He is an active board member of three US based portfolio companies including Marillion, a cancer drug company; Melior, a pharmaceutical services company; and Bioserve, apharmacogenomics services company.Bobba's extensive experience in building life sciences products and businesses is leveraged by his portfolio companies. He helped one company double their revenues recently with an acquisition, and led the transformation of another portfolio company to being product focused when the existing technology platform focus was yielding limited results.Bobba has previously served as Senior Vice President of operations at Aradigm Corporation; Executive Vice President at Diosynth, a division of Akzo Nobel; President and CEO at Molecular Biosystems, an NYSE listed company; Executive Vice President at Centocor Inc;(A division of J&J now) President at Warner-Lambert, Imdonesia (currently a part of Pfizer) in Indonesia, and Vice President of Manufacturing in Puerto Rico; and Vice President of Manufacturing, Parke Davis, A division of Lambert which is now part of Pfizer. Bobba also serves on the advisory Boards of SOHO Group, the third largest Pharmaceutical Company in Indonesia and Cumberland Pharmaceuticals Inc, USA, a NASADAQ listed company.A pharmacist by training, Bobba graduated with gold medal honors from Andhra University. He also has an MBA from Fairleigh Dickinson University, New Jersey. Apart from his directorships of portfolio companies, Bobba also serves on the boards of Sparsha Pharma, India's first transdermal drug delivery company, and the Indian subsidiary of Napo Pharmaceuticals, a California based company.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries Bobba Venkatadri invests in
Stages Bobba Venkatadri invests in
Countries Bobba Venkatadri invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 2 (67%)
- Fitness 1 (33%)
- Medical 1 (33%)
- Hospital 1 (33%)
- Wellness 1 (33%)
Stage
- Seed 1 (33%)
- Series A 1 (33%)
- Series B 1 (33%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Celes Care is India’s first Online Health Clinic for Women. We offer doctor consultation services on Pregnancy Care, Nutrition, Wellness & General Health. Our online consultation service is highly affordable and delivered by our expert women doctors who are compassionate and care for your health. We connect you with our doctors within a minute. | $1.5M / Seed / Feb 28, 2017 | ||
| Portea Medical is India’s home healthcare pioneer and the largest and fastest growing provider of in-home medical care in India today with a 24-city network. Portea’s comprehensive services encompass geriatric care, post-operative care, palliative care and physiotherapy. The company offers home visits from physiotherapists, nursing attendants,nurses and doctors. In addition, Portea also provides collection of lab samples from patients’ homes and medical equipment on hire, bringing the entire gamut of healthcare services to a patient’s doorstep. | $37.5M / Series B / Sep 20, 2015 | ||
| Portea Medical is India’s home healthcare pioneer and the largest and fastest growing provider of in-home medical care in India today with a 24-city network. Portea’s comprehensive services encompass geriatric care, post-operative care, palliative care and physiotherapy. The company offers home visits from physiotherapists, nursing attendants,nurses and doctors. In addition, Portea also provides collection of lab samples from patients’ homes and medical equipment on hire, bringing the entire gamut of healthcare services to a patient’s doorstep. | $9M / Series A / Dec 02, 2013 |
Co-Investors
About VenturEast
They like to partner the entrepreneur that is trying to avoid doing the commonplace; one that is growing with the current trend but is preparing to lead the next trend. You are a mature India based businessman; you are a tech-savvy entrepreneur returning from overseas; or you are a corporate/scientific establishment employee …all are appealingto them, your drive to make a difference is what they are looking for.
VenturEast Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bobba Venkatadri
General Partner
|
|||
|
Aditya Kapil
Principal
|
|||
|
C. Shekhar Kundur
General Partner
|
|||
Dr. Ramesh Byrapaneni
Venture Partner
|
|||
Praveen Yelchuru
Assistant Vice President - Finance
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Bobba Venkatadri invest in?
Bobba Venkatadri invests primarily in Health Care, Fitness and Medical startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in India. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bobba Venkatadri?
Public channels for Bobba Venkatadri include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Bobba Venkatadri last invest?
The most recent investment recorded for Bobba Venkatadri closed in Feb 2017. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
